Astrana Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Astrana Health, Inc. on June 13, 2024. The report addresses corporate governance actions taken following the Company's 2024 Annual Meeting of Stockholders held on June 12, 2024.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate amendments and does not contain financial performance data.
Material Changes
On June 13, 2024, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Delaware Secretary of State, which became effective immediately upon filing. This amendment implements a provision approved by stockholders to exculpate certain officers from liability for claims brought by stockholders, as permitted under Section 102(b)(7) of the Delaware General Corporation Law.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific operational risks. The document references a Definitive Proxy Statement on Schedule 14A filed on April 24, 2024, for a more detailed summary of the amendment.
Key Facts for Investor Verification
- Stockholders approved an amendment to the Restated Certificate of Incorporation at the June 12, 2024 Annual Meeting.
- The amendment provides exculpation for certain officers from liability under Delaware law.
- The Certificate of Amendment was filed and became effective on June 13, 2024.
- The full text of the Certificate of Amendment is available as Exhibit 3.1 to this filing.